96 related articles for article (PubMed ID: 25087948)
1. Dynorphin a (1-13) alleviated stress-induced behavioral impairments in mice.
Mamiya T; Hasegawa Y; Hiramatsu M
Biol Pharm Bull; 2014; 37(8):1269-73. PubMed ID: 25087948
[TBL] [Abstract][Full Text] [Related]
2. Opioid receptor agonists selective for mu and kappa receptors attenuate methamphetamine-induced behavioral sensitization in the mouse.
Toyoshi T; Ukai M; Kameyama T
Biol Pharm Bull; 1996 Mar; 19(3):369-74. PubMed ID: 8924903
[TBL] [Abstract][Full Text] [Related]
3. Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous kappa-opioid receptor agonist.
Hiramatsu M; Murasawa H; Mori H; Kameyama T
Br J Pharmacol; 1998 Mar; 123(5):920-6. PubMed ID: 9535021
[TBL] [Abstract][Full Text] [Related]
4. Effects of dynorphin A-(1-13) on carbon monoxide-induced delayed amnesia in mice studied in a step-down type passive avoidance task.
Hiramatsu M; Sasaki M; Kameyama T
Eur J Pharmacol; 1995 Aug; 282(1-3):185-91. PubMed ID: 7498274
[TBL] [Abstract][Full Text] [Related]
5. Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice.
Zhang Y; Butelman ER; Schlussman SD; Ho A; Kreek MJ
Psychopharmacology (Berl); 2004 Apr; 172(4):422-9. PubMed ID: 14712335
[TBL] [Abstract][Full Text] [Related]
6. Improvement by dynorphin A (1-13) of galanin-induced impairment of memory accompanied by blockade of reductions in acetylcholine release in rats.
Hiramatsu M; Mori H; Murasawa H; Kameyama T
Br J Pharmacol; 1996 May; 118(2):255-60. PubMed ID: 8735624
[TBL] [Abstract][Full Text] [Related]
7. Dynorphin A(1-13) modulates apomorphine-induced behaviors using multidimensional behavioral analyses in the mouse.
Ukai M; Toyoshi T; Kameyama T
Brain Res; 1989 Oct; 499(2):299-304. PubMed ID: 2572301
[TBL] [Abstract][Full Text] [Related]
8. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
[TBL] [Abstract][Full Text] [Related]
9. Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat.
Amat J; Matus-Amat P; Watkins LR; Maier SF
Brain Res; 1998 Nov; 812(1-2):113-20. PubMed ID: 9813270
[TBL] [Abstract][Full Text] [Related]
10. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice.
Itoh J; Ukai M; Kameyama T
J Pharmacol Exp Ther; 1994 Apr; 269(1):15-21. PubMed ID: 7909556
[TBL] [Abstract][Full Text] [Related]
11. Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice.
Itoh J; Ukai M; Kameyama T
Eur J Pharmacol; 1993 Jun; 236(3):341-5. PubMed ID: 8102969
[TBL] [Abstract][Full Text] [Related]
12. Valeriana officinalis root extract suppresses physical stress by electric shock and psychological stress by nociceptive stimulation-evoked responses by decreasing the ratio of monoamine neurotransmitters to their metabolites.
Jung HY; Yoo DY; Kim W; Nam SM; Kim JW; Choi JH; Kwak YG; Yoon YS; Hwang IK
BMC Complement Altern Med; 2014 Dec; 14():476. PubMed ID: 25495725
[TBL] [Abstract][Full Text] [Related]
13. Activity wheel running reduces escape latency and alters brain monoamine levels after footshock.
Dishman RK; Renner KJ; Youngstedt SD; Reigle TG; Bunnell BN; Burke KA; Yoo HS; Mougey EH; Meyerhoff JL
Brain Res Bull; 1997; 42(5):399-406. PubMed ID: 9092882
[TBL] [Abstract][Full Text] [Related]
14. Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice.
Kuzmin A; Madjid N; Terenius L; Ogren SO; Bakalkin G
Neuropsychopharmacology; 2006 Sep; 31(9):1928-37. PubMed ID: 16292317
[TBL] [Abstract][Full Text] [Related]
15. Influence of stress on regional brain serotonin metabolism after progesterone treatment and upon plasma progesterone in the rat.
Ladisich W
J Neural Transm; 1975; 36(1):33-42. PubMed ID: 1120948
[TBL] [Abstract][Full Text] [Related]
16. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
[TBL] [Abstract][Full Text] [Related]
17. Dynorphin A(1-13) preferentially inhibits behaviors induced by the D2 dopamine agonist RU 24213 but not by the D1 dopamine agonist SK&F 38393.
Ukai M; Toyoshi T; Kameyama T
Pharmacol Biochem Behav; 1992 Aug; 42(4):755-9. PubMed ID: 1355296
[TBL] [Abstract][Full Text] [Related]
18. Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2.
Sakurada S; Sawai T; Mizoguchi H; Watanabe H; Watanabe C; Yonezawa A; Morimoto M; Sato T; Komatsu T; Sakurada T
Peptides; 2008 Sep; 29(9):1554-60. PubMed ID: 18571771
[TBL] [Abstract][Full Text] [Related]
19. Dynorphin A-(1-13) potently improves galanin-induced impairment of memory processes in mice.
Kameyama T; Ukai M; Miura M
Neuropharmacology; 1994 Oct; 33(10):1167-9. PubMed ID: 7532287
[TBL] [Abstract][Full Text] [Related]
20. Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice.
Hiramatsu M; Sasaki M; Nabeshima T; Kameyama T
Pharmacol Biochem Behav; 1997 Jan; 56(1):73-9. PubMed ID: 8981612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
